Expanding the Scope of the National Practice Oncology Benchmark Would Be a Critical Source for Understanding Outpatient Oncology Practice Costs and Profits in a Time of Change

nork Conti, Rena M.
Argitaratua izan da J Oncol Pract (2015)

The Societal Benefit of Nonprofit Biotechnology Companies

nork Conti, Rena M.
Argitaratua izan da Clin Adv Hematol Oncol (2008)

Problems With Public Reporting of Cancer Quality Outcomes Data

nork Goldberg, Paul, Conti, Rena M.
Argitaratua izan da J Oncol Pract (2014)

Public research funding and pharmaceutical prices: do Americans pay twice for drugs?

nork Conti, Rena M., David, Frank S.
Argitaratua izan da F1000Res (2020)

Cost Consequences of the 340B Drug Discount Program

nork Conti, Rena M., Bach, Peter B.
Argitaratua 2013

Improving Outpatient Oncology Practice: Several Steps Into a Long Journey

nork Conti, Rena M., Bach, Peter B.
Argitaratua izan da J Oncol Pract (2014)

The 340B Drug Discount Program: Hospitals Generate Profits By Expanding To Reach More Affluent Communities

nork Conti, Rena M., Bach, Peter B.
Argitaratua izan da Health Aff (Millwood) (2014)

Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014

nork Chua, Kao-Ping, Conti, Rena M.
Argitaratua izan da JAMA Intern Med (2017)

Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014

nork Chua, Kao-Ping, Conti, Rena M.
Argitaratua izan da J Gen Intern Med (2018)

FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETS

nork Conti, Rena M., Berndt, Ernst R.
Argitaratua izan da Int J Econ Bus (2019)

Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage

nork Chua, Kao-Ping, Conti, Rena M.
Argitaratua izan da Am J Prev Med (2021)

Trends in Orphan Drug Spending And Out-of-Pocket Spending Among US Children, 2013–18

nork Chua, Kao-Ping, Conti, Rena M.
Argitaratua izan da Health Aff (Millwood) (2020)

Diversity of Participants in the 340B Drug Pricing Program for US Hospitals

nork Nikpay, Sayeh, Buntin, Melinda, Conti, Rena M.
Argitaratua izan da JAMA Intern Med (2018)

Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist

nork Polite, Blase, Conti, Rena M., Ward, Jeffery C.
Argitaratua izan da Am Soc Clin Oncol Educ Book (2015)

National Trends In Spending On And Use Of Oral Oncologics, First Quarter 2006 Through Third Quarter 2011

nork Conti, Rena M., Fein, Adam J., Bhatta, Sumita S.
Argitaratua izan da Health Aff (Millwood) (2014)

A pediatric-focused review of the performance incentive literature

nork Chien, Alyna T., Conti, Rena M., Pollack, Harold A.
Argitaratua izan da Curr Opin Pediatr (2007)

Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016

nork Conti, Rena M., Nikpay, Sayeh S., Buntin, Melinda B.
Argitaratua izan da JAMA Netw Open (2019)

Relationship between initiation of 340B participation and hospital safety‐net engagement

nork Nikpay, Sayeh S., Buntin, Melinda B., Conti, Rena M.
Argitaratua izan da Health Serv Res (2020)

Pharmacy benefit manager reform: lessons from Ohio

nork Royce, Trevor J., Kircher, Sheetal, Conti, Rena M.
Argitaratua izan da JAMA (2019)

Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases

nork Chua, Kao-Ping, Kimmel, Lauren, Conti, Rena M.
Argitaratua izan da Health Aff (Millwood) (2021)